D.C. sue to block 23andMe's data sale amid bankruptcy proceedings. Regeneron Pharmaceuticals' $256 million acquisition faces ...

Regeneron Pharmaceuticals said on Monday it will buy genomics firm 23andMe Holding for $256 million through a bankruptcy ...

Lawmakers want to know what will be done to make sure consumer genetic testing company 23andMe’s data will stay out of the ...

WilmerHale said it’s representing the law professor tapped to make privacy-related recommendations about the sale of ...

States sue to halt Regeneron's 23andMe acquisition, citing privacy concerns over user DNA data, as a court-ordered report on ...